Astrana Health, Inc. (ASTH)
38.76
+0.47
(+1.23%)
USD |
NASDAQ |
Jun 10, 16:00
38.76
0.00 (0.00%)
After-Hours: 20:00
Astrana Health Enterprise Value : 2.238B for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 2.238B |
| June 08, 2026 | 2.243B |
| June 05, 2026 | 2.223B |
| June 04, 2026 | 2.217B |
| June 03, 2026 | 2.160B |
| June 02, 2026 | 2.171B |
| June 01, 2026 | 2.212B |
| May 29, 2026 | 2.205B |
| May 28, 2026 | 2.240B |
| May 27, 2026 | 2.249B |
| May 26, 2026 | 2.250B |
| May 22, 2026 | 2.217B |
| May 21, 2026 | 2.194B |
| May 20, 2026 | 2.261B |
| May 19, 2026 | 2.288B |
| May 18, 2026 | 2.272B |
| May 15, 2026 | 2.237B |
| May 14, 2026 | 2.281B |
| May 13, 2026 | 2.310B |
| May 12, 2026 | 2.273B |
| May 11, 2026 | 2.222B |
| May 08, 2026 | 2.288B |
| May 07, 2026 | 2.130B |
| May 06, 2026 | 2.089B |
| May 05, 2026 | 2.086B |
| Date | Value |
|---|---|
| May 04, 2026 | 2.076B |
| May 01, 2026 | 2.072B |
| April 30, 2026 | 2.035B |
| April 29, 2026 | 2.078B |
| April 28, 2026 | 2.072B |
| April 27, 2026 | 2.029B |
| April 24, 2026 | 2.014B |
| April 23, 2026 | 1.976B |
| April 22, 2026 | 2.013B |
| April 21, 2026 | 1.957B |
| April 20, 2026 | 1.903B |
| April 17, 2026 | 1.906B |
| April 16, 2026 | 1.862B |
| April 15, 2026 | 1.795B |
| April 14, 2026 | 1.787B |
| April 13, 2026 | 1.778B |
| April 10, 2026 | 1.716B |
| April 09, 2026 | 1.746B |
| April 08, 2026 | 1.706B |
| April 07, 2026 | 1.722B |
| April 06, 2026 | 1.637B |
| April 02, 2026 | 1.590B |
| April 01, 2026 | 1.564B |
| March 31, 2026 | 1.564B |
| March 30, 2026 | 1.617B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilon Health, Inc. | 1.427B |
| The Oncology Institute, Inc. | 570.45M |
| Nakamoto, Inc. | 248.96M |
| American Oncology Network, Inc. | -- |
| DaVita, Inc. | 27.39B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 13.13M |
| Revenue (Quarterly) | 965.10M |
| Total Expenses (Quarterly) | 950.66M |
| EPS Diluted (Quarterly) | 0.2943 |
| Gross Profit Margin (Quarterly) | 9.35% |
| Profit Margin (Quarterly) | 1.36% |
| Earnings Yield | 1.58% |
| Operating Earnings Yield | 4.52% |
| Normalized Earnings Yield | 1.544 |